Omalizumab for the Treatment of Multiple Food AllergiesRobert A. Wood, R. Sharon Chinthrajah, Donald Y.M. Leung et al.|New England Journal of Medicine|2024Cited by 298
Phase 2a randomized, placebo-controlled study of anti–IL-33 in peanut allergyR. Sharon Chinthrajah, Kari C. Nadeau, Shu Cao et al.|JCI Insight|2019Cited by 188
A Phase 2 Randomized Controlled Multisite Study Using Omalizumab-facilitated Rapid Desensitization to Test Continued vs Discontinued Dosing in Multifood Allergic IndividualsSandra Andorf, Kari C. Nadeau, Natasha Purington et al.|EClinicalMedicine|2019Cited by 132